Download - IN HIS NAME
![Page 1: IN HIS NAME](https://reader035.vdocuments.us/reader035/viewer/2022062410/568165be550346895dd8bf51/html5/thumbnails/1.jpg)
IN HIS NAME
![Page 2: IN HIS NAME](https://reader035.vdocuments.us/reader035/viewer/2022062410/568165be550346895dd8bf51/html5/thumbnails/2.jpg)
Surgery or colonoscopy???
That is the problem!!!!
![Page 3: IN HIS NAME](https://reader035.vdocuments.us/reader035/viewer/2022062410/568165be550346895dd8bf51/html5/thumbnails/3.jpg)
Acute colonic pseudo-obstruction (ACPO) is characterised by massive colonic dilation with symptoms and signs of colonic obstruction without mechanical blockage
Ischemia and perforation are the feared complications of ACPO
INTRODUCTION
![Page 4: IN HIS NAME](https://reader035.vdocuments.us/reader035/viewer/2022062410/568165be550346895dd8bf51/html5/thumbnails/4.jpg)
Ischemia and perforation are the feared
complications of ACPO Spontaneous perforation has been reported in
3%–15% of cases with a mortality rate estimated at 50% or higher when this occurs .
The main issues for the clinician to consider are: (1) what is the correct diagnosis? (2) Is ischemia or perforation present? (3) What is the appropriate evaluation and management?
INTRODUCTION
![Page 5: IN HIS NAME](https://reader035.vdocuments.us/reader035/viewer/2022062410/568165be550346895dd8bf51/html5/thumbnails/5.jpg)
Colonic pseudoobstruction was first described
in 1948 by Sir Heneage Ogilvie, who reported two patients with chronic colonic dilation associated with malignant infiltration of the celiac plexus.
An imbalance in autonomic innervation, produced by a variety of factors, leads to excessive parasympathetic suppression or sympathetic stimulation
PATHOGENESIS
![Page 6: IN HIS NAME](https://reader035.vdocuments.us/reader035/viewer/2022062410/568165be550346895dd8bf51/html5/thumbnails/6.jpg)
In comparison to control patients, patients
who developed ACPO had significantly lower postoperative serum sodium, a higher serum urea and remained in hospital longer
Predisposing factors
![Page 7: IN HIS NAME](https://reader035.vdocuments.us/reader035/viewer/2022062410/568165be550346895dd8bf51/html5/thumbnails/7.jpg)
![Page 8: IN HIS NAME](https://reader035.vdocuments.us/reader035/viewer/2022062410/568165be550346895dd8bf51/html5/thumbnails/8.jpg)
ACPO most often affects those in late middle age
(mean of 60 years of age), with a slight male predominance (60%)
ACPO occurs almost exclusively in hospitalised or institutionalised patients with serious underlying medical and surgical conditions. Abdominal distention usually develops over 3–7 days but can occur as rapidly as 24–48 h.7 In surgical patients, symptoms and signs develop at a mean of 5 days postoperatively.
CLINICAL PRESENTATION
![Page 9: IN HIS NAME](https://reader035.vdocuments.us/reader035/viewer/2022062410/568165be550346895dd8bf51/html5/thumbnails/9.jpg)
abdominal distention (80 %) abdominal pain (80%) nausea and/or vomiting (60%) Passage of flatus or stool is reported in up to
40% of patients high incidence of fever inpatients with
ischemic or perforated bowel
clinical features
![Page 10: IN HIS NAME](https://reader035.vdocuments.us/reader035/viewer/2022062410/568165be550346895dd8bf51/html5/thumbnails/10.jpg)
suggested by the clinical presentation and
confirmed by plain abdominal radiographs, which show varying degrees of colonic dilation
The right colon and cecum show the most marked distention, and ‘cutoffs’ at the splenic flexure and descending colon are common
DIAGNOSIS
![Page 11: IN HIS NAME](https://reader035.vdocuments.us/reader035/viewer/2022062410/568165be550346895dd8bf51/html5/thumbnails/11.jpg)
![Page 12: IN HIS NAME](https://reader035.vdocuments.us/reader035/viewer/2022062410/568165be550346895dd8bf51/html5/thumbnails/12.jpg)
MANAGEMENT
![Page 13: IN HIS NAME](https://reader035.vdocuments.us/reader035/viewer/2022062410/568165be550346895dd8bf51/html5/thumbnails/13.jpg)
outcome
![Page 14: IN HIS NAME](https://reader035.vdocuments.us/reader035/viewer/2022062410/568165be550346895dd8bf51/html5/thumbnails/14.jpg)
spontaneous perforation to be approximately
3%. The risk of colonic perforation has been
reported to increase with cecal diameter greater than 12 cm and when distention has been present for more than 6 days
A two-fold increase in mortality occurs when cecal diameter is greater than 14 cm and a fivefold increase when delay in decompression is greater than seven days.
outcome
![Page 15: IN HIS NAME](https://reader035.vdocuments.us/reader035/viewer/2022062410/568165be550346895dd8bf51/html5/thumbnails/15.jpg)
Treatment options for ACPO include
appropriate supportive measures, pharmacologic therapy, colonoscopic decompression, and surgery
Treatment
![Page 16: IN HIS NAME](https://reader035.vdocuments.us/reader035/viewer/2022062410/568165be550346895dd8bf51/html5/thumbnails/16.jpg)
Supportive therapy
![Page 17: IN HIS NAME](https://reader035.vdocuments.us/reader035/viewer/2022062410/568165be550346895dd8bf51/html5/thumbnails/17.jpg)
patients with marked cecal distention (>10
cm) of significant duration (>3–4 days) and those not improving after 24–48 h of supportive therapy are candidates for further intervention
Treatment
![Page 18: IN HIS NAME](https://reader035.vdocuments.us/reader035/viewer/2022062410/568165be550346895dd8bf51/html5/thumbnails/18.jpg)
Neostigmine: a reversible acetylcholinesterase inhibitor administered intravenously, has a rapid onset of action(1–20 min) short duration (1–2 h) The elimination half-life averages 80 min
Medical therapy
![Page 19: IN HIS NAME](https://reader035.vdocuments.us/reader035/viewer/2022062410/568165be550346895dd8bf51/html5/thumbnails/19.jpg)
Contraindications to its use include
mechanical obstruction,presence of ischemia or perforation, pregnancy, uncontrolled cardiac arrhythmias, severe active bronchospasm, and renal insufficiency (serum creatinine >3 mg/dL).
Neostigmin
![Page 20: IN HIS NAME](https://reader035.vdocuments.us/reader035/viewer/2022062410/568165be550346895dd8bf51/html5/thumbnails/20.jpg)
Colonic decompression is the initial invasive
procedure of choice for patients with marked cecal distention (>10 cm) of significant duration (>3–4 days), not improving after 24–48 h of supportive therapy, and who have contraindications to or fail neostigmine.
It should not be performed if overt peritonitis or perforation are present
Colonoscopic decompression
![Page 21: IN HIS NAME](https://reader035.vdocuments.us/reader035/viewer/2022062410/568165be550346895dd8bf51/html5/thumbnails/21.jpg)
there are case reports of patients with
ischemia in ACPO being successfully managed with colonoscopic decompression
Oral laxatives and bowel preparations should not be administered prior to colonoscopy
Prolonged attempts at cecal intubation are notnecessary because reaching the hepatic flexure usually suffices
Colonoscopic decompression
![Page 22: IN HIS NAME](https://reader035.vdocuments.us/reader035/viewer/2022062410/568165be550346895dd8bf51/html5/thumbnails/22.jpg)
Colonoscopic
decompression
![Page 23: IN HIS NAME](https://reader035.vdocuments.us/reader035/viewer/2022062410/568165be550346895dd8bf51/html5/thumbnails/23.jpg)
![Page 24: IN HIS NAME](https://reader035.vdocuments.us/reader035/viewer/2022062410/568165be550346895dd8bf51/html5/thumbnails/24.jpg)
Eff icacy successful colonoscopic decompression has
been reported in many retrospective series In the series reported by Geller et al:Acute colonic pseudo-obstruction was diagnosed in 50 patients; . Forty-one patients (82%) had one colonoscopic decompression with clinical success in 39 (95%). Nine patients (18%) required multiple (2 to 4) colonoscopic decompressions with clinical success in 5 (56%)
Colonoscopic decompression
![Page 25: IN HIS NAME](https://reader035.vdocuments.us/reader035/viewer/2022062410/568165be550346895dd8bf51/html5/thumbnails/25.jpg)
the overall clinical success of colonoscopic
decompression was 88%. However, in procedures where a decompression tube was not placed the clinical success was poor (25%).
Colonoscopic decompression
![Page 26: IN HIS NAME](https://reader035.vdocuments.us/reader035/viewer/2022062410/568165be550346895dd8bf51/html5/thumbnails/26.jpg)
![Page 27: IN HIS NAME](https://reader035.vdocuments.us/reader035/viewer/2022062410/568165be550346895dd8bf51/html5/thumbnails/27.jpg)
![Page 28: IN HIS NAME](https://reader035.vdocuments.us/reader035/viewer/2022062410/568165be550346895dd8bf51/html5/thumbnails/28.jpg)
Safety: The complication rate of decompression
colonoscopy in ACPO ranges from approximately 1 to 5%
Perforation is the most complication
Colonoscopic decompression
![Page 29: IN HIS NAME](https://reader035.vdocuments.us/reader035/viewer/2022062410/568165be550346895dd8bf51/html5/thumbnails/29.jpg)
can be considered in high surgical risk
patients reserved for patients failing neostigmine and
colonoscopic decompression who have no evidence of ischemia or perforation and who are felt to be at high risk for surgery.
Percutaneous cecostomy
![Page 30: IN HIS NAME](https://reader035.vdocuments.us/reader035/viewer/2022062410/568165be550346895dd8bf51/html5/thumbnails/30.jpg)
Surgical management is reserved for patients
with signs of colonic ischemia or perforation or who fail endoscopic and pharmacologic effort
Without perforated or ischemic bowel, cecostomy is the procedure of choice.
In cases of ischemic or perforated bowel,segmental or subtotal resection is indicated
Surgical therapy
![Page 31: IN HIS NAME](https://reader035.vdocuments.us/reader035/viewer/2022062410/568165be550346895dd8bf51/html5/thumbnails/31.jpg)
Everyone can enjoy of life but
just some of them can pick up
a scalple and save the lifes.